What is the main business of Diagovet?

The main business activity of Diagovet focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 18, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Gen. Władysława Andersa 38A, 15-113 Białystok.

Who is on the management board?

The management board consists of: Andrzej Andrzejewski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $1,417,984, representing an increase of 82.4% compared to 2024.

Yes, the company recorded a net profit of $17,055 in 2025, meaning the company increased its profit by 81.5%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $975,004 in 2025, representing 70% of all operating expenses.

Diagovetsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-01-18

Share capital

100,000.00 PLN

Registered address

ul. Gen. Władysława Andersa 38A, 15-113 Białystok, Poland

Financials

Revenue history (in k)

Financial insight

The statement flags a going concern risk.

Filing timeliness

Financial statements were filed on time, on average 59 days early.

202524/04/2026
202410/06/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.42mMedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD 17.05kMedianUSD 37.33kAverageUSD 879.18k

Operating costs

This companyUSD 1.40mMedianUSD 926.31kAverageUSD 21.06m

Assets

This companyUSD 311.73kMedianUSD 609.81kAverageUSD 11.84m

Industry

Authorized Representatives

Andrzej Andrzejewski – President of the Management Board

Manner of representation

In the case of a one-person management board, one member of the management board is authorized to make declarations on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Andrzej Andrzejewskiage 48	970	$26,202.05	97%
Others	30	$810.37	3%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-03-01.

ING Bank Śląski
63 1050 1953 1000 0090 8328 8945

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Mar 16, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$243$243	Marszałek Województwa Podlaskiego
Mar 17, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$372$372	Marszałek Województwa Podlaskiego

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A.	$146,864,520.79	multipharme.pl
DiagnosisS.A.	$37,413,735.72	diagnosis.pl
Cirrosp. z o.o.	$20,863,166.14	cirro.pl
Premmier Redsp. z o.o.	$2,723,178.99	premmier.com
Novicaresp. z o.o.	$1,512,398.66	novicare.pl
CryoprofilS.A.	$1,470,469.25	cryoprofil.pl
Medimessp. z o.o.	$1,228,073.80	medimes.pl
Optimed Pro-Office Cirrosp. j.	$1,276,876.90	cirro.pl
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.	$1,264,523.63	sonomedical.pl
Temedasp. z o.o.	–	temeda.pl